1: Matsumura Y, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S. In vitro
activities and detection performances of cefmetazole and flomoxef for
extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing
Enterobacteriaceae. Diagn Microbiol Infect Dis. 2015 Dec 11. pii:
S0732-8893(15)00438-1. doi: 10.1016/j.diagmicrobio.2015.12.001. [Epub ahead of
print] PubMed PMID: 26782634.
2: Matsumura Y, Yamamoto M, Nagao M, Komori T, Fujita N, Hayashi A, Shimizu T,
Watanabe H, Doi S, Tanaka M, Takakura S, Ichiyama S. Multicenter retrospective
study of cefmetazole and flomoxef for treatment of
extended-spectrum-β-lactamase-producing Escherichia coli bacteremia. Antimicrob
Agents Chemother. 2015 Sep;59(9):5107-13. doi: 10.1128/AAC.00701-15. Epub 2015
Jun 22. PubMed PMID: 26100708; PubMed Central PMCID: PMC4538479.